Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers
Status:
Completed
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the hypothesis that ingestion of the wake-inhibiting
drug suvorexant 30 minutes prior to daytime sleep initiation in individuals working overnight
shifts will significantly improve both objective (total sleep time, sleep efficiency, wake
after sleep onset) and subjective (sleep quality) measures of daytime sleep.